Nachrichten der Wirtschaftskanzleien
Student Athlete Class Action Against UNC Chapel Hill Dismissed
El Pollo Loco Secures Second Dismissal of Securities Complaint
AXA Equitable Wins New SLUSA Dismissal of Variable Annuity Case
Intellectually Disabled Client Granted Relief by Supreme Court
National CinemaChain Sells Cinema Park
Parrot Automotive and Faurecia Form Partnership
Nippon Shokubai to Acquire Sirrus
Gumi to Establish Joint Venture With Nordisk Film
DuPont/Dow Merger Approved by EU
China-Based AirMedia Secures Dismissal of Class Action Complaint
Skadden Named International Arbitration Team of the Year
Sealed Air to Sell New Diversey to Bain Capital Private Equity
French State to Sell Interest in Peugeot
Former CFTC General Counsel Jonathan L. Marcus Joins Skadden as Of Counsel
Olswang advises two new VC clients on Series B investment round in British biotech Pulmocide
International technology, media and telecoms law firm Olswang has advised venture capital firms SR One Ltd and Longwood Fund III LP for the first time, on their Series B round of investment of Pulmocide Limited, a biotech developing two treatments for deadly viral and fungal lung infections.
The $30 million (£24 million) cash injection is Pulmocide's second, having already secured $17 million in an initial fundraising round. In addition to SR One and Longwood Fund, the fresh funds come from Pulmocide's existing backers including venture capital firm SV Life Sciences, J&J DC, the venture capital arm of Johnson & Johnson, Touchstone Innovations and F-prime, the venture capital arm of Fidelity.
Olswang Corporate Partner Niall McAlister commented: "It was a pleasure to advise SR One and Longwood Fund III on their investment in Pulmocide. This significant investment follows Pulmocide's strong track record of clinical success and these monies will go a long way to developing two critical treatments currently being developed – one for babies with Respiratory Syncytial Virus and the other for fungal infection Aspergillosis."
Niall McAlister led the transaction along with IP Partner and Head of Life Sciences Robert Stephen, Corporate Senior Associate Kate Blumhof, IP Associate Hemma Lad, Share Schemes Legal Director Catherine Merry and Trainee Alex Lowe.
Read more about Olswang’s international legal practice on the firm’s website.
(ENDS)
Skadden Leads in Handling Defense-Side Federal Securities Cases
Triangle USA Petroleum Secures Approval for Reorganization Plan
Citigroup Sells APAC Customer Portfolio for Merchant Acquiring
PIK Group Announces Tender Offer and Cancellation of Listing
Olswang advises Spotify on its acquisition of audio detection start-up Sonalytic
International technology, media and telecoms law firm Olswang has advised global music streaming giant Spotify on its acquisition of Sonalytic, the UK-based makers of audio detection technology that identifies songs, mixed content and audio clips.
Sonalytic's technology will help improve Spotify's personalised playlists, match songs with compositions and improve Spotify's publishing data system.
Olswang advised Spotify on all areas of the transaction, deploying specialist technology experts from a range of practice areas.
Peter Grandelius, Head of Corporate Legal, Spotify, commented: "We were glad to have Olswang's support on this strategic acquisition, which will help Spotify improve our unique music ecosystem. The team at Olswang delivered committed, integrated and specialised advice under a tight timeframe. We look forward to working with them in the future."
Olswang Corporate Partner Louis Glass, who led the transaction for the firm, commented: "We loved working with the Spotify team on this exciting transaction and in particular with Peter and his legal colleague Nicolina Kindblom. As avid users of Spotify, we're keen to see how Sonalytic's audio feature detection will advance Spotify's offering."
(ENDS)
